Compare E & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | E | A |
|---|---|---|
| Founded | 1953 | 1999 |
| Country | Italy | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Laboratory Analytical Instruments |
| Sector | Energy | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 79.1B | 38.0B |
| IPO Year | 2002 | 1999 |
| Metric | E | A |
|---|---|---|
| Price | $54.60 | $156.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 15 |
| Target Price | $28.00 | ★ $161.47 |
| AVG Volume (30 Days) | 312.1K | ★ 1.7M |
| Earning Date | 04-24-2026 | 05-27-2026 |
| Dividend Yield | ★ 2.97% | 0.92% |
| EPS Growth | N/A | ★ 3.16 |
| EPS | N/A | ★ 3.55 |
| Revenue | N/A | ★ $4,472,000,000.00 |
| Revenue This Year | $11.36 | $8.45 |
| Revenue Next Year | N/A | $6.13 |
| P/E Ratio | ★ $21.46 | $44.04 |
| Revenue Growth | N/A | ★ 6.43 |
| 52 Week Low | $34.07 | $108.35 |
| 52 Week High | $58.00 | $163.75 |
| Indicator | E | A |
|---|---|---|
| Relative Strength Index (RSI) | 49.35 | 62.13 |
| Support Level | $52.28 | $135.76 |
| Resistance Level | $55.46 | $163.75 |
| Average True Range (ATR) | 0.82 | 3.85 |
| MACD | -0.11 | 0.23 |
| Stochastic Oscillator | 39.51 | 95.72 |
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2025, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At year-end 2025, Eni held reserves of 6.9 billion barrels of oil equivalent, 44% of which are liquids. The Italian government owns a 33.1% stake in the company. Plentitude, Eni's renewable and low-carbon business, has 5.8 gigawatts of renewable power capacity, serves 10 million electricity customers, and operates 23,000 electric vehicle charging points.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and diagnostics, cross lab operations consisting of consumables and services, and applied end markets. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.